Home
Conditions
Lymphoma, Large-Cell, Immunoblastic

Clinical trial condition

Lymphoma, Large-Cell, Immunoblastic

Explore clinical trials studying Lymphoma, Large-Cell, Immunoblastic. Study availability and eligibility vary by location and protocol.

372 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Large-Cell, Immunoblastic trial results

Completed

Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer

NCT00036790

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +126 more
Locations: Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States

University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States

View Trial Details

Completed

Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors

NCT01326702

Conditions: Adult B Acute Lymphoblastic Leukemia, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Adult Solid Neoplasm, +88 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma

NCT00049712

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
Locations: University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States

View Trial Details

Completed

Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer

NCT00003270

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +57 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders

NCT00856388

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, +179 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

NCT00003397

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +22 more
Locations: Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States

View Trial Details

Completed

Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00006350

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +51 more
Locations: Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States

View Trial Details

Completed

Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

NCT00105001

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, +173 more
Locations: Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States

Emory University/Winship Cancer Institute Atlanta, Georgia, United States

Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States

LDS Hospital Salt Lake City, Utah, United States

View Trial Details

Completed

Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00003396

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +60 more
Locations: Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States

View Trial Details

Completed

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

NCT00003398

Conditions: Anemia, Blast Crisis, Blood Protein Disorders, +64 more
Locations: Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States

View Trial Details

Lymphoma, Large-Cell, Immunoblastic

Lymphoma, Large-Cell, Immunoblastic trial results

Related conditions